Delivery Order SPE2DB22D3016-SPE2DB25FAFY2

Award Date 12/10/24
Potential Completion Date 12/11/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAFY2
    Delivery Order

This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAFY2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,438.32 Firm Fixed Price Delivery Order is for the supply of 4566675940 DAPAGLIFLOZIN 10 MG Tablets, a medication used to manage diabetes. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award was not designated with a set-aside requirement, indicating open competition.

Generated 3/11/25, 9:55 AM